SEC Form 4 · accession 0001127602-16-056322
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Benkowitz
Officer — President and COO
Period of report
Jun 26, 2016
Accepted (ET)
Jun 27, 2016 · 9:23 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $102.11 | Jun 26, 2016 | A | 52,500 | A | Jun 26, 2017 | Jun 26, 2026 | Common Stock | 52,500 | 52,500 | D |
Explanation of responses
- F1These stock options were granted in connection with the reporting person's promotion to President and Chief Operating Officer, and vest in one-fourth increments on each of June 26, 2017, 2018, 2019 and 2020.